{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:39:24Z","timestamp":1783615164819,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["733051072"],"award-info":[{"award-number":["733051072"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nucmedbio.2025.109581","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:52:47Z","timestamp":1763639567000},"page":"109581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration"],"prefix":"10.1016","volume":"152-153","author":[{"given":"Jaime D.","family":"Mondragon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Marcolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Lima","family":"Giacobbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Elsinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi A.J.O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Tollenaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debby","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"De Deyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2025.109581_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/2398212820930321","article-title":"The role of the locus coeruleus in the generation of pathological anxiety","volume":"4","author":"Morris","year":"2020","journal-title":"Brain Neurosci Adv"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110751","article-title":"Norepinephrine system at the interface of attention and reward","volume":"125","author":"Zhang","year":"2023","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.neuro.28.061604.135709","article-title":"An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance","volume":"28","author":"Aston-Jones","year":"2005","journal-title":"Annu Rev Neurosci"},{"issue":"8","key":"10.1016\/j.nucmedbio.2025.109581_bb0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. Translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109581_bb0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3233\/JAD-160320","article-title":"Brain serotonergic and noradrenergic deficiencies in behavioral variant frontotemporal dementia compared to early-onset Alzheimer\u2019s disease","volume":"53","author":"Vermeiren","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109581_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-022-02477-6","article-title":"Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus-pericoerulear complex by three-dimensional imaging","volume":"144","author":"Gilvesy","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109581_bb0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/WCO.0b013e32835a3432","article-title":"Where, when, and in what form does sporadic Alzheimer\u2019s disease begin?","volume":"25","author":"Braak","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2017.12.027","article-title":"Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer\u2019s disease pathogenesis: potential strategies to protect the LC against aging","volume":"1702","author":"Satoh","year":"2019","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109581_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bpa.12289","article-title":"Precortical phase of Alzheimer\u2019s disease (AD)-related tau cytoskeletal pathology","volume":"26","author":"Stratmann","year":"2016","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109581_bb0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","article-title":"Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery","volume":"13","author":"Theofilas","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109581_bb0055","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1523\/JNEUROSCI.17-05-01710.1997","article-title":"Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei","volume":"17","author":"Ordway","year":"1997","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2006.03717.x","article-title":"The norepinephrine transporter and its regulation","volume":"97","author":"Mandela","year":"2006","journal-title":"J Neurochem"},{"issue":"30","key":"10.1016\/j.nucmedbio.2025.109581_bb0065","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.2174\/138161206778559687","article-title":"PET imaging of norepinephrine transporters","volume":"12","author":"Ding","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109581_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/syn.20696","article-title":"PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT","volume":"64","author":"Ding","year":"2010","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109581_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/syn.10281","article-title":"Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs","volume":"50","author":"Ding","year":"2003","journal-title":"Synapse"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109581_bb0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.nucmedbio.2007.03.013","article-title":"Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress","volume":"34","author":"Logan","year":"2007","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109581_bb0085","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/jc.2017-02717","article-title":"Noradrenergic activity in the human brain: a mechanism supporting the defense against hypoglycemia","volume":"103","author":"Belfort-DeAguiar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109581_bb0090","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0095","volume":"18","author":"Smith","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.appet.2017.06.020","article-title":"Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availability","volume":"117","author":"Bresch","year":"2017","journal-title":"Appetite"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/eat.22621","article-title":"Emotional eating and in vivo norepinephrine transporter availability in obesity: a [11 C]MRB PET pilot study","volume":"50","author":"Bresch","year":"2017","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pscychresns.2017.06.013","article-title":"The association between in vivo central noradrenaline transporter availability and trait impulsivity","volume":"267","author":"Hesse","year":"2017","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2013.10.004","article-title":"Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine","volume":"86","author":"Li","year":"2014","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109581_bb0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ijo.2015.216","article-title":"The central nervous norepinephrine network links a diminished sense of emotional well-being to an increased body weight","volume":"40","author":"Melasch","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109581_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/10253890.2018.1511698","article-title":"Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls","volume":"22","author":"Schinke","year":"2019","journal-title":"Stress"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109581_bb0130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00259-018-4002-7","article-title":"Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults","volume":"45","author":"Vettermann","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ijnp\/pyx066","article-title":"A positron emission tomography study of norepinephrine transporter occupancy and its correlation with symptom response in depressed patients treated with quetiapine XR","volume":"21","author":"Yatham","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12149-018-1305-5","article-title":"PET imaging of noradrenaline transporters in Parkinson\u2019s disease: focus on scan time","volume":"33","author":"Brumberg","year":"2019","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109581_bb0145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2967\/jnumed.117.190975","article-title":"Noradrenergic deficits in Parkinson disease imaged with 11C-MeNER [published correction appears in J Nucl Med. 2018 Sep;59(9):1473]","volume":"59","author":"Nahimi","year":"2018","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/brain\/awx348","article-title":"Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study","volume":"141","author":"Sommerauer","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnagi.2018.00127","article-title":"Noradrenergic dysfunction in Alzheimer\u2019s and Parkinson\u2019s diseases-an overview of imaging studies","volume":"10","author":"Peterson","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109581_bb0160","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awab236","article-title":"Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson\u2019s disease","volume":"144","author":"Doppler","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105295","article-title":"Preserved noradrenergic function in Parkinson\u2019s disease patients with rest tremor","volume":"152","author":"Kinnerup","year":"2021","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.dadm.2019.02.001","article-title":"Locus coeruleus MRI contrast is reduced in Alzheimer\u2019s disease dementia and correlates with CSF A\u03b2 levels","volume":"11","author":"Betts","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"10.1016\/j.nucmedbio.2025.109581_bb0175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41562-019-0715-2","article-title":"Rostral locus coeruleus integrity is associated with better memory performance in older adults","volume":"3","author":"Dahl","year":"2019","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.583421","article-title":"What\u2019s that (blue) spot on my MRI? Multimodal neuroimaging of the locus coeruleus in neurodegenerative disease","volume":"14","author":"Kelberman","year":"2020","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109581_bb0185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neuroimage.2009.06.012","article-title":"In vivo mapping of the human locus coeruleus","volume":"47","author":"Keren","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","article-title":"Histologic validation of locus coeruleus MRI contrast in post-mortem tissue","volume":"113","author":"Keren","year":"2015","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109581_bb0195","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41380-023-02041-y","article-title":"Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau","volume":"28","author":"Van Egroo","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109581_bb0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","article-title":"Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"26","author":"Szot","year":"2006","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109581_bb0205","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/brain\/awz193","article-title":"Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases","volume":"142","author":"Betts","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109581_bb0210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/biomet\/87.4.954","article-title":"A new family of power transformations to improve normality or symmetry","volume":"87","author":"Yeo","year":"2000","journal-title":"Biometrika"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0215","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1007\/s10994-021-05960-5","article-title":"Transforming variables to central normality","volume":"113","author":"Raymaekers","year":"2024","journal-title":"Mach Learn"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109581_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41398-020-0841-7","article-title":"Correlation between cognition and plasma noradrenaline level in Alzheimer\u2019s disease: a potential new blood marker of disease evolution","volume":"10","author":"Pillet","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109581_bb0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nucmedbio.2025.109581_bb0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease","volume":"9","author":"Gigu\u00e8re","year":"2018","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109581_bb0235","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol Psychiatry"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125005906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125005906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:33:01Z","timestamp":1777602781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125005906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0969805125005906"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109581","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating [11C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109581"}}